Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank89
3Y CAGR-33.9%
Studio
Year-over-Year Change

Diluted earnings per share

3Y CAGR
-33.9%/yr
Annual compound
Percentile
P89
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM0.75+225.0%
2024-0.60-400.0%
20230.20-92.3%
20222.60+213.0%
2021-2.30+11.9%
2020-2.61+12.7%
2019-2.99+14.3%
2018-3.49-74.5%
2017-2.00-170.3%
2016-0.74-